1. Cánovas, Verónica, Lleonart, Matilde, Morote, Juan, Paciucci, Rosanna. . The role of prostate tumor overexpressed 1 in cancer progression. In Oncotarget, 8, 12451-12471. doi:10.18632/oncotarget.14104. https://pubmed.ncbi.nlm.nih.gov/28029646/
2. Xie, Si-An, Zhang, Wen, Du, Feng, Zhang, Shu-Tian, Zhu, Sheng-Tao. 2024. PTOV1 facilitates colorectal cancer cell proliferation through activating AKT1 signaling pathway. In Heliyon, 10, e36017. doi:10.1016/j.heliyon.2024.e36017. https://pubmed.ncbi.nlm.nih.gov/39229496/
3. Li, Rong, Leng, Ai-Min, Liu, Xiao-Ming, Zhou, Yan-Wu, Xu, Can-Xia. . Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 39, 1010428317705013. doi:10.1177/1010428317705013. https://pubmed.ncbi.nlm.nih.gov/28651486/
4. Liu, Fashun, Li, Zhen, Wan, Songlin, Ye, Zhenxiong, Li, Daojiang. 2023. Pan-cancer analysis confirms the prognostic and immunological effects of prostate tumor overexpressed-1 in human cancers. In Current cancer drug targets, , . doi:10.2174/1568009623666230316153813. https://pubmed.ncbi.nlm.nih.gov/36927431/
5. Chi, Xiaobin, Chen, Zhijian, Chen, Yongbiao, Yu, Jianda, Lv, Lizhi. 2023. Upregulation of lncRNA PTOV1-AS1 in hepatocellular carcinoma contributes to disease progression and sorafenib resistance through regulating miR-505. In Journal of biochemical and molecular toxicology, 37, e23437. doi:10.1002/jbt.23437. https://pubmed.ncbi.nlm.nih.gov/37352125/
6. Wu, Zhiqiang, Liu, Zhuang, Jiang, Xiangli, Zheng, Boyu, Yuan, Zhiyong. 2019. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits. In Journal of experimental & clinical cancer research : CR, 38, 341. doi:10.1186/s13046-019-1349-y. https://pubmed.ncbi.nlm.nih.gov/31387622/
智鼠故事 
